Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Inveready
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Home About us Our research About us Our vision: To establish ocular hydration as a new standard in preventive healthcare, unlocking earlier…
TearSolutionsVenture round $517k · 10 mo ago • Founded 2015 • 51-200 employees
NATURAL THERAPY FOR OCULAR SURFACE DISEASE. TearSolutions has developed LacripepTM, a proprietary first-in-class peptide therapy.
Secretome TherapeuticsSeries A $30M · 4 mo ago • Founded 2018 • 11-50 employees
Developing Novel Therapies from Neonatal Cardiac Progenitor Cells. Consistent, potent, and scalable neonatal cell sources designed for…
Cayuga Biotech is developing novel therapies to address life-threatening hemorrhage byharnessing the body’s innate ability to stop bleeding.
Novel Immunotherapeutics for Inflammatory Injury, Fibrosis and Vascular Leak. We focus on developing novel therapies for diseases with…
Ikerian AGSeries B $8M · 23 mo ago • 11-50 employees
We harmonize, standardize and analyze multimodal healthcare data to enable the right decisions sooner in healthcare.

Overview

Innerva Pharmaceuticals is an innovative ophthalmic startup developing novel therapies for ocular surface pain.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Barcelona Spain
Regional office
Let's get in touch
08028 Barcelona, Spain
company site